Back
Oncternal Therapeutics Vs. Dave Industry Stock Comparison
Sell
32
ONCT
Oncternal Therapeutics
Last Price:
1.18
Seasonality Move:
21.38%
Buy
99
DAVE
Dave
Last Price:
79.94
Seasonality Move:
82.07%
Sell
32
Oncternal Therapeutics (ONCT)
is a Sell
Is Oncternal Therapeutics a Buy, Sell or Hold?
- The current Oncternal Therapeutics [ONCT] share price is $1.14. The Score for ONCT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- ONCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
99
Dave (DAVE)
is a Buy
Is Dave a Buy, Sell or Hold?
- The current Dave [DAVE] share price is $90.46. The Score for DAVE is 99, which is 98% above its historic median score of 50, and infers lower risk than normal.
- DAVE is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
ONCT Stock Price Chart
What is Oncternal Therapeutics's stock price today?
-
The Oncternal Therapeutics share price today is $1.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ONCT is experiencing slight selling pressure.
ONCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 36.88 | Sell |
| Chaikin Money Flow: | -45884 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.19 - 1.65) | Sell |
| Bollinger Bands (100): | (1.45 - 6.37) | Sell |
DAVE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.7 | Buy |
| Relative Strength Index (14 RSI): | 89.82 | Buy |
| Chaikin Money Flow: | 1682432 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.65 - 56.79) | Buy |
| Bollinger Bands (100): | (31.2 - 46.26) | Buy |
ONCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.38 | Sell |
| 20-day SMA: | 1.49 | Sell |
| 50-day SMA: | 1.74 | Sell |
| 200-day SMA: | 6.38 | Sell |
| 8-day EMA: | 1.33 | Sell |
| 20-day EMA: | 1.44 | Sell |
| 50-day EMA: | 2.11 | Sell |
| 200-day EMA: | 5.37 | Sell |
DAVE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.07 | Buy |
| 20-day SMA: | 46.26 | Buy |
| 50-day SMA: | 42.24 | Buy |
| 200-day SMA: | 37.25 | Buy |
| 8-day EMA: | 59.69 | Buy |
| 20-day EMA: | 49.96 | Buy |
| 50-day EMA: | 44.12 | Buy |
| 200-day EMA: | 35.62 | Buy |
Oncternal Therapeutics Earnings Growth & ONCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.51 per share, and an increase next year of $1.64 per share.
Dave Earnings Growth & DAVE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.36 per share.
Oncternal Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Dave Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||